Satoru Sugisawa

Satoru Sugisawa

Auto-generated profile, based on publicly available information

Satoru Sugisawa

Department of Hospital Pharmaceutics, School of Pharmacy Showa University Tokyo Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2022 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
PDF file
SSSatoru Sugisawa
Satoru Sugisawa
TKTatsuya Kurihara
Tatsuya Kurihara
YNYukako Nakano
Yukako Nakano
TTToshiaki Tsuneoka
Toshiaki Tsuneoka
HKHiroaki Koya
Hiroaki Koya
AIAkira Iwanami
Akira Iwanami
Background: We conducted a historical cohort study of patients with schizophrenia to identify more robust risk factors at discharge that contribute to readmission within a year.Methods and Findings: The subjects underwent brief psychoeducation during hospitalization. Multivariate analysis was conducted using factors selected in the univariate analysis. Using logistic regression analysis, the number of hospital admissions (P = .01) and Schedule for Assessment of Insight Japanese version score (P = .04) were identified as risk factors for readmission, with odds ratios of 0.70 and 1.18, respectively.Conclusions: These results suggest that improvement in insight and early intervention may lead to a more stable community life.

28 April 2022 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
TNTsutomu Nagai
Tsutomu Nagai
TKTatsuya Kurihara
Tatsuya Kurihara
HKHiroaki Koya
Hiroaki Koya
YNYukako Nakano
Yukako Nakano
SSSatoru Sugisawa
Satoru Sugisawa
NUNaoki Uchida
Naoki Uchida
Aim Atomoxetine (ATX) is a non-central stimulant and a standard treatment for adult attention-deficit/hyperactivity disorder (ADHD). The long-term efficacy of Atomoxetine is about 40% at 6 months. The variability in efficacy between individuals is thought to be related to patient-specific factors, but no detailed research has been conducted. In this retrospective cohort study, we aimed to identify the factors associated with Atomoxetine efficacy. Methods A total of 147 patients with attention-deficit/hyperactivity disorder aged >= 18 years who were using Atomoxetine for the first time were included in this study. The outcome was treatment success (treatment maintained for at least 6 months and improvement in symptoms). Symptom assessment was based on the overall improvement in symptoms judged by an expert physician. Results Of the patient sample, 103 (70.1%) achieved the outcome. Logistic regression analysis identified "the maximum dose of ATX" and "gambling habit" as factors associated with efficacy ( P < 0.05). In the process of Atomoxetine titration, the larger the maximum dose, the higher the efficacy was shown to be. Gambling habits may be indicative of impulsivity, which is among the core symptoms of attention-deficit/hyperactivity disorder. Thus, a gambling habit may be considered a surrogate marker for impulsivity. Conclusions Knowledge of these factors will help healthcare professionals to predict the likely efficacy of Atomoxetine in a given patient before subscribing it, facilitating individualized pharmacotherapy for adult attention-deficit/hyperactivity disorder.

26 February 2020 in Perspectives in Psychiatric Care
Verified
Journal Article
Closed access
PDF file
SSSatoru Sugisawa
Satoru Sugisawa
SNShinji Nozue
Shinji Nozue
TKTatsuya Kurihara
Tatsuya Kurihara
HKHiroaki Koya
Hiroaki Koya
TTToshiaki Tsuneoka
Toshiaki Tsuneoka
TSTadanori Sasaki
Tadanori Sasaki

1 November 2011 in YAKUGAKU ZASSHI
Verified
Journal Article
Closed access
ISIsao Saito
Isao Saito
MKMari Kogo
Mari Kogo
AKAya Kobayashi
Aya Kobayashi
TWToru Watanabe
Toru Watanabe
SASeiji Abe
Seiji Abe
JMJun-Ichiro Murayama
Jun-Ichiro Murayama
We have previously reported the efficacy of the Patient Oriented Clerkship (POC) in the clinical clerkship in Showa University Hospitals, by a trial with old four-year pharmacy program students. In the unique clerkship, each student has a patient in charge, and follows his/her clinical conditions throughout the rotation. The aim of the POC is that having the students learn spontaneously (Active Learning) and actively (Adult Learning) promoted by student's commitment and responsibility by communicating with patients and health professionals in a team. As the POC requires students both Active Learning and Adult Learning, we define the POC as Active Adult Learning (AAL). Having a patient in charge for each student gives them many opportunities to participate in the medical team and foster their problem solving skills. Our previous study eventually showed positive results of the POC in the one-month short clerkship in the four-year program. On the other hand, the effect of the unique hospital clerkship in the new six-year program is not known. We conducted a student survey to clarify the learning effect in the new six-year education system which was revised and 2.5 month clinical clerkship was scheduled according to the model core clerkship curriculum. This report is the first report to show a challenge of the AAL/POC clerkship in the new six-year pharmacy education program.